|
Opinion
Whispers
of hope
Market
Exploring
the unexplores
Inspite of being controversy's child, stem cell therapy offers
new hope to patients with diseases earlier considered incurable.
This increased focus on stem cell research is seeing more
investment in R&D. Suja Nair explores
Government
launches BIPP
The Cabinet Committee on Economic Affairs (CCEA) has approved
the launch of a new scheme called Biotechnology Industry Partnership
Programme (BIPP), an advanced technology science scheme
Partnering
ahead
Ram Shelat, Director-Domestic Business, Shreya Life Sciences,
speaks to Sachin Jagdale about company’s business strategies
and world’s first recombinant DNA human insulin buccal
spray, Oral- Recosulin, that Shreya Life Sciences launched
recently
Technology
On
the edge of tomorrow
The Indian Genome Variation Consortium (IGVC) set out on a
mission to provide a genetic basis for the complicated case
of the Indian setting. Divya Pamnani reviews the IGVC project
and its implications for the future of pharmacogenomics in
India
|
